RNF11 at the Crossroads of Protein Ubiquitination.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
11 11 2020
Historique:
received: 29 09 2020
revised: 06 11 2020
accepted: 08 11 2020
entrez: 14 11 2020
pubmed: 15 11 2020
medline: 8 9 2021
Statut: epublish

Résumé

RNF11 (Ring Finger Protein 11) is a 154 amino-acid long protein that contains a RING-H2 domain, whose sequence has remained substantially unchanged throughout vertebrate evolution. RNF11 has drawn attention as a modulator of protein degradation by HECT E3 ligases. Indeed, the large number of substrates that are regulated by HECT ligases, such as ITCH, SMURF1/2, WWP1/2, and NEDD4, and their role in turning off the signaling by ubiquitin-mediated degradation, candidates RNF11 as the master regulator of a plethora of signaling pathways. Starting from the analysis of the primary sequence motifs and from the list of RNF11 protein partners, we summarize the evidence implicating RNF11 as an important player in modulating ubiquitin-regulated processes that are involved in transforming growth factor beta (TGF-β), nuclear factor-κB (NF-κB), and Epidermal Growth Factor (EGF) signaling pathways. This connection appears to be particularly significant, since RNF11 is overexpressed in several tumors, even though its role as tumor growth inhibitor or promoter is still controversial. The review highlights the different facets and peculiarities of this unconventional small RING-E3 ligase and its implication in tumorigenesis, invasion, neuroinflammation, and cancer metastasis.

Identifiants

pubmed: 33187263
pii: biom10111538
doi: 10.3390/biom10111538
pmc: PMC7697665
pii:
doi:

Substances chimiques

DNA-Binding Proteins 0
RNF11 protein, human 0
Ubiquitin 0
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 2013 N14135

Références

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5282-7
pubmed: 19289835
Mol Cell. 2003 Jan;11(1):249-59
pubmed: 12535537
J Proteome Res. 2010 Jun 4;9(6):3280-9
pubmed: 20415495
J Neuroinflammation. 2012 Apr 16;9:67
pubmed: 22507528
Nucleic Acids Res. 2012 Sep;40(16):8048-58
pubmed: 22684508
J Leukoc Biol. 2018 Feb 1;:
pubmed: 29389019
Oncogene. 2004 Mar 11;23(10):1801-8
pubmed: 14755250
Life Sci Alliance. 2020 Apr 17;3(6):
pubmed: 32303586
Int J Mol Sci. 2019 Jun 05;20(11):
pubmed: 31195692
Dev Cell. 2011 Jul 19;21(1):77-91
pubmed: 21763610
EMBO J. 2009 Mar 4;28(5):513-22
pubmed: 19131965
Mol Cell Biol. 2009 Jun;29(12):3307-18
pubmed: 19364824
J Virol. 2013 Apr;87(7):3782-91
pubmed: 23345523
J Cell Biol. 2014 Apr 28;205(2):143-53
pubmed: 24751536
Mov Disord. 2005 Oct;20(10):1299-309
pubmed: 15966006
Front Plant Sci. 2013 Aug 01;4:293
pubmed: 23914201
Oncogene. 2013 Oct 31;32(44):5220-32
pubmed: 23222715
Trends Cell Biol. 2004 Mar;14(3):103-6
pubmed: 15055197
J Parkinsons Dis. 2017;7(1):31-63
pubmed: 27802243
Mol Syst Biol. 2010 Jun 8;6:371
pubmed: 20531401
Oncogene. 2015 Jun;34(26):3377-90
pubmed: 25195858
Nature. 2014 Jun 5;510(7503):162-6
pubmed: 24784582
Biochim Biophys Acta. 2014 Jan;1843(1):47-60
pubmed: 23747565
Biochim Biophys Acta. 2014 Jan;1843(1):114-28
pubmed: 23845989
Science. 2005 Jul 1;309(5731):127-30
pubmed: 15994556
J Biol Chem. 2001 Oct 26;276(43):39501-4
pubmed: 11527981
J Biol Chem. 2003 Sep 19;278(38):35857-60
pubmed: 12860974
Proteomics. 2004 Jun;4(6):1633-49
pubmed: 15174133
Curr Opin Cell Biol. 2007 Apr;19(2):176-84
pubmed: 17317136
Trends Cell Biol. 2014 Jan;24(1):26-34
pubmed: 24295852
Annu Rev Biochem. 2012;81:203-29
pubmed: 22524316
Proteins. 2009 Jan;74(1):92-103
pubmed: 18615712
EMBO Rep. 2011 Apr;12(4):342-9
pubmed: 21399620
Neoplasia. 2006 Aug;8(8):689-95
pubmed: 16925951
Biochim Biophys Acta. 2014 Jan;1843(1):61-74
pubmed: 23545411
FEBS Lett. 2018 Apr;592(8):1434-1444
pubmed: 29537486
J Biol Chem. 2017 May 5;292(18):7435-7451
pubmed: 28292929
Curr Opin Struct Biol. 2020 Jun;62:189-196
pubmed: 32305021
Cancer Res. 2014 Sep 15;74(18):4955-66
pubmed: 25172841
Anticancer Res. 2009 Jun;29(6):2253-63
pubmed: 19528490
FEBS J. 2019 Feb;286(4):653-677
pubmed: 30659753
Cell Biochem Biophys. 2011 Jun;60(1-2):39-46
pubmed: 21448666
Neurosci Lett. 2013 Jun 28;547:16-20
pubmed: 23669642
Biol Chem. 2018 Jan 26;399(2):127-145
pubmed: 29016349
Cell Res. 2016 Apr;26(4):399-422
pubmed: 27012465
Nat Rev Mol Cell Biol. 2007 Jan;8(1):74-84
pubmed: 17183362
Nature. 2004 Aug 5;430(7000):694-9
pubmed: 15258597
Mol Cell Proteomics. 2012 Aug;11(8):215-29
pubmed: 22645316
Annu Rev Immunol. 2009;27:693-733
pubmed: 19302050
Nat Struct Mol Biol. 2013 Jun;20(6):696-701
pubmed: 23644597
Mol Cell. 2011 Oct 21;44(2):325-40
pubmed: 21906983
Traffic. 2002 Oct;3(10):740-51
pubmed: 12230472
Mol Cell Proteomics. 2014 Jan;13(1):63-72
pubmed: 24105792
Biochem J. 2014 Mar 15;458(3):421-37
pubmed: 24576094
J Biol Chem. 2009 May 1;284(18):12071-9
pubmed: 19252184
Mol Cancer Res. 2005 Aug;3(8):453-61
pubmed: 16123141
J Biol Chem. 2004 Mar 19;279(12):11471-9
pubmed: 14684745
Mol Cell Proteomics. 2012 Dec;11(12):1578-85
pubmed: 22790023
J Exp Med. 2011 Jun 6;208(6):1189-201
pubmed: 21555486
Nat Cell Biol. 2012 Jun 03;14(7):764-74
pubmed: 22660414
J Biochem. 2010 Jun;147(6):793-8
pubmed: 20418328
Neoplasia. 2006 Aug;8(8):677-88
pubmed: 16925950
Am J Transl Res. 2015 Sep 15;7(9):1629-35
pubmed: 26550462
Structure. 2011 Aug 10;19(8):1033-5
pubmed: 21827939
Curr Biol. 2016 Jan 25;26(2):173-183
pubmed: 26748853
Eur J Cancer. 2005 Nov;41(16):2549-60
pubmed: 16226459
Oncogene. 2008 Nov 20;27(54):6845-55
pubmed: 18724389
Nat Immunol. 2008 Mar;9(3):254-62
pubmed: 18246070
Trends Biochem Sci. 2016 Nov;41(11):924-937
pubmed: 27614784
Annu Rev Biochem. 2009;78:399-434
pubmed: 19489725
Biochim Biophys Acta. 1999 Dec 23;1489(2-3):421-7
pubmed: 10673045
Nat Struct Mol Biol. 2016 Jan;23(1):45-52
pubmed: 26656854
Cell. 2010 Dec 23;143(7):1174-89
pubmed: 21183079
EMBO J. 2009 Mar 4;28(5):455-6
pubmed: 19262463
J Proteomics. 2014 Jan 16;96:253-62
pubmed: 24275569
Mol Cell. 2008 Jun 20;30(6):689-700
pubmed: 18570872
Nat Cell Biol. 2006 Nov;8(11):1246-54
pubmed: 17013377
J Biol Chem. 2003 Apr 25;278(17):15429-34
pubmed: 12591926
Methods Enzymol. 2014;535:225-47
pubmed: 24377927
PLoS One. 2013 Sep 09;8(9):e73683
pubmed: 24040025
Ann Neurol. 2002 Nov;52(5):549-55
pubmed: 12402251
Biochim Biophys Acta. 2003 Oct 15;1639(2):104-12
pubmed: 14559117
FEBS J. 2020 Aug;287(16):3526-3550
pubmed: 31985874
Mol Cell. 2006 Feb 17;21(4):481-93
pubmed: 16483930
Exp Cell Res. 2009 May 15;315(9):1610-8
pubmed: 19007773
J Biol Chem. 2010 Feb 26;285(9):6308-15
pubmed: 20026602
BMC Biochem. 2007 Nov 22;8 Suppl 1:S14
pubmed: 18047738
Biochem J. 2014 May 15;460(1):127-39
pubmed: 24660806
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a003350
pubmed: 20300215
Cell Mol Life Sci. 2018 Sep;75(17):3121-3141
pubmed: 29858610
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1401-E1408
pubmed: 29378950
Biochimie. 2008 Feb;90(2):270-83
pubmed: 17961905
J Cell Biol. 2004 Aug 16;166(4):487-92
pubmed: 15314065
J Neuropathol Exp Neurol. 2007 Oct;66(10):955-64
pubmed: 17917589
PLoS One. 2013;8(1):e53717
pubmed: 23308279
Front Endocrinol (Lausanne). 2016 Aug 08;7:109
pubmed: 27551276
Mol Biol Cell. 2014 Jun 15;25(12):1892-904
pubmed: 24790097
Cell Mol Life Sci. 2012 May;69(9):1425-34
pubmed: 22051607
Trends Biochem Sci. 2003 Nov;28(11):612-8
pubmed: 14607092
Neurosci Lett. 2012 Oct 24;528(2):174-9
pubmed: 22975135
Neurosci Lett. 2012 Jun 27;520(1):104-9
pubmed: 22634524
Genome Res. 2009 Oct;19(10):1905-11
pubmed: 19549727
Oncogene. 2010 Oct 14;29(41):5604-18
pubmed: 20676133
Genome Med. 2020 Feb 18;12(1):17
pubmed: 32070411
J Cell Biol. 2004 Apr;165(1):135-44
pubmed: 15078904
J Cell Biol. 2008 Mar 24;180(6):1205-18
pubmed: 18362181
Front Microbiol. 2019 Aug 27;10:2006
pubmed: 31507581
Science. 2013 Jun 21;340(6139):1451-5
pubmed: 23661642
Science. 2010 Feb 26;327(5969):1135-9
pubmed: 20185725
PLoS Genet. 2012;8(3):e1002581
pubmed: 22438830
Mol Cell. 2009 Dec 25;36(6):1095-102
pubmed: 20064473
J Cell Biol. 2016 Nov 21;215(4):543-558
pubmed: 27872256
Genome Res. 2004 Jul;14(7):1324-32
pubmed: 15231748
Oncogene. 2004 Mar 15;23(11):2089-95
pubmed: 15021896
Nucleic Acids Res. 2018 Jan 4;46(D1):D428-D434
pubmed: 29136216
Br J Cancer. 2003 Oct 20;89(8):1538-44
pubmed: 14562029
Cancer Cell. 2008 Jul 8;14(1):10-21
pubmed: 18598940

Auteurs

Anna Mattioni (A)

Department of Biology, University of Rome Tor Vergata, Via della ricerca scientifica, 00133 Rome, Italy.

Luisa Castagnoli (L)

Department of Biology, University of Rome Tor Vergata, Via della ricerca scientifica, 00133 Rome, Italy.

Elena Santonico (E)

Department of Biology, University of Rome Tor Vergata, Via della ricerca scientifica, 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH